Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    INTP Gross Margin

    As of 2025-07-10, the Gross Margin of Integrated Pharmaceuticals Inc (INTP) is 64.9%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    INTP Gross Margin - Historical Value
    DateValue
    2007-12-31 64.9%
    2006-12-31 8.2%
    2005-12-31 41.6%
    2004-12-31 -
    2003-12-31 35.6%
    -
    -
    -
    -
    -
    INTP Gross Margin - Peers Comparison
    TickerNameValue
    ACCAAcacia Diversified Holdings Inc4.9%
    ATT.CNAbattis Bioceuticals Corp67.6%
    BSPKBespoke Extracts Inc40.5%
    CBDXCurative Biosciences Inc34.8%
    CHM.CNChemistree Technology Inc25.5%
    CIG.CNCamarico Investment Group Ltd-155.7%
    CXUSCelexus Inc13.9%
    EAPHEaston Pharmaceuticals Inc12.9%
    ETSTEarth Science Tech Inc65.5%
    GNOM.CNGnomestar Craft Inc-56.9%
    GSAC41.2%
    MDINNorthstar Global Business Services Inc50%
    NGBLNotis Global Inc-5.6%
    NOUVNouveau Life Pharmaceuticals Inc7775.2%
    NSHS.CNNanoSphere Health Sciences Inc7775.2%
    NXENNexien Biopharma Inc16.6%
    PLSIPhoenix Life Sciences International Ltd27.1%
    POT.CNPotent Ventures Inc6%
    PRVBProvention Bio Inc96%
    RCPIQRock Creek Pharmaceuticals Inc-49.6%
    RLSC.CNRise Life Science Corp6291.3%
    RSPIRespireRx Pharmaceuticals Inc7775.2%
    SIGOSunset Island Group Inc7775.2%
    SYUPANBC Inc-115.7%
    ULURAltrazeal Life Sciences Inc68%
    VOQPVioquest Pharmaceuticals Inc43.6%
    Tickers added to watchlist